Skip to main content
SpringerLink
Log in

Regulation of the human papillomavirus oncoproteins by differential phosphorylation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Human papillomaviruses (HPVs) are intimately associated with the development of cervical cancer. The virus encodes two oncoproteins, E6 and E7, that are primarily responsible for inducing malignant transformation. The last few years have seen significant progress in elucidating the mechanisms by which these two viral proteins bring about cell transformation. Both proteins interact with a large number of cellular targets, many of which are involved in regulating diverse functions such as cell cycle regulation, transcription, differentiation and apoptosis. However both E6 and E7 are normally present at low levels within the virally infected cell, and how all these interactions are achieved and regulated has, until recently, been unclear. We have found that both E6 and E7 are subject to differential phosphorylation, the net results of which regulate their abilities to interact with some of their respective target proteins. In the case of E6, phosphorylation by Protein Kinase A (PKA) negatively regulates its ability to interact with the Discs Large (Dlg) tumour suppressor. In the case of E7, phosphorylation by Casein Kinase II (CKII) significantly increases its ability to interact with the TATA Box Binding Protein (TBP). Further, CKII regulation of E7 appears to vary during the cell cycle, therefore this provides a means of specifically targeting E7 to a given substrate at a given point within the cell cycle. This differential regulation of E6 and E7 by phosphorylation thus provides specificity to a diverse set of protein-protein interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827–841, 1999

    Google Scholar 

  2. de Villiers EM: Human pathogenic papillomavirus types: An update. Curr Top Microbiol Immunol 186: 1–12, 1994

    Google Scholar 

  3. zur Hausen H, Schneider A: The role of papillomaviruses in human anogenital cancers. 1987 In: N. Salzman, P.M. Howley (eds). The Papovaviridae, vol 2. New York, Plenum Press, pp 245–263

    Google Scholar 

  4. Schwarz E, Freese U, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111–114, 1985

    Google Scholar 

  5. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119: 361–366, 1985

    Google Scholar 

  6. Smotkin D, Wettstein F: Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line, and identification of the E7 protein. Proc Natl Acad Sci USA 83: 4680–4684, 1986

    Google Scholar 

  7. Androphy EJ, Hubbert N, Schiller JT, Lowy DR: Identification of the HPV 16 E6 protein from transformed mouse cells and human cervical carcinoma cells. EMBO J 6: 989–992, 1987

    Google Scholar 

  8. Banks L, Spence P, Androphy E, Hubbert N, Matlashewski G, Murray A, Crawford L: Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol 68: 1351–1359, 1987

    Google Scholar 

  9. Alvarez-Salas LM, Cullinan AE, Siwkowski A, Hampel A, DiPaolo JA: Inhibition of HPV-16 E6/E7 immortalisation of normal keratinocytes by hairpin ribozymes. Proc Natl Acad Sci USA 95: 1189–1194, 1998

    Google Scholar 

  10. von Knebel Doeberitz M, Rittmuller C, zur Hausen H, Durst M: Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer 51: 831–834, 1992

    Google Scholar 

  11. Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F: Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci USA 97: 6693–6697, 2000

    Google Scholar 

  12. Kanda T, Furuno A, Yoshiike K: Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J. Virol 62: 610–613, 1988

    Google Scholar 

  13. Vousden KH, Doniger J, DiPaolo JA, Lowy DR: The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res 3: 167–175, 1988

    Google Scholar 

  14. Storey A, Pim D, Murray A, Osborn K, Banks L, Crawford L: Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 7: 1815–1820, 1988

    Google Scholar 

  15. Storey A, Banks L: Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalise primary mouse cells. Oncogene 8: 919–924, 1993

    Google Scholar 

  16. Wazer DE, Liu XL, Chu Q, Gao Q, Band V: Immortalisation of distinct human mammary epithelial cell types by human papillomavirus 16 E6 or E7. Proc Natl Acad Sci USA 92: 3687–3691, 1995

    Google Scholar 

  17. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417–4423, 1989

    Google Scholar 

  18. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT: HPV 16 E6 and E7 proteins cooperate to immortalise human foreskin keratinocytes. EMBO J 8: 3905–3910, 1989

    Google Scholar 

  19. Dürst M, Gallahan D, Gilbert J, Rhim JS: Glucocorticoid enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173: 767–771, 1989

    Google Scholar 

  20. DiPaolo J, Woodworth C, Popescu MC, Notario V, Doniger J: Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4: 395–399, 1989

    Google Scholar 

  21. Werness B, Levine A, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76–79, 1990

    Google Scholar 

  22. Dyson N, Howley PM, Münger K, Harlow E: The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–936, 1989

    Google Scholar 

  23. Sato H, Furuno A, Yoshiike K: Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells. Virology 168: 195–199, 1989

    Google Scholar 

  24. Banks L, Edmonds C, Vousden KH: Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5: 1383–1389, 1990

    Google Scholar 

  25. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR: Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90: 3988–3992, 1993

    Google Scholar 

  26. Foster SA, Demers GW, Etscheid BG, Galloway DA: The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol 68: 5698–5705, 1994

    Google Scholar 

  27. Davies R, Hicks R, Crook T, Morris J, Vousden KH: Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 67: 2521–2528, 1993

    Google Scholar 

  28. Dyson N, Guida P, Münger, K, Harlow E: Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66: 6893–6902, 1992

    Google Scholar 

  29. McIntyre MC, Ruesch M, Laimins L: Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 215: 73–82, 1996

    Google Scholar 

  30. Tommasino M, Adamczewski J P, Carlotti F, Barth CF, Manetti R, Contorni M, Cavalieri F, Hunt T, Crawford L: HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8: 195–202, 1993

    Google Scholar 

  31. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Dürr P: Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13: 2323–2330, 1996

    Google Scholar 

  32. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA: Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 11: 2090–2100, 1997

    Google Scholar 

  33. Jones DL, Alani RM, Münger K: The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21cip1-mediated inhibition of cdk2. Genes Dev 11: 2101–2111, 1997

    Google Scholar 

  34. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424–429, 1992

    Google Scholar 

  35. Massimi P, Pim D, Storey A, and Banks L: HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12: 2325–2330, 1996

    Google Scholar 

  36. Antinore M, Birrer M, Patel D, Nader L, McCance J: The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP-1 family of transcription factors. EMBO J 15: 1950–1960, 1996

    Google Scholar 

  37. Massimi P, Pim D, Banks L: Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. J Gen Virol 78: 2607–2613, 1997

    Google Scholar 

  38. Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH: Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transcription and suppresses anchorage independent growth of HPV immortalised human keratinocytes. Oncogene 16: 2711–2721, 1998

    Google Scholar 

  39. Kühne C, Banks L: E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J Biol Chem 273: 34302–34309, 1998

    Google Scholar 

  40. Patel D, Huang SM, Baglia LA, McCance DJ: The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18: 5061–5072, 1998

    Google Scholar 

  41. Thomas M, Banks L: Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17: 2943–2954, 1998

    Google Scholar 

  42. Jackson S, Harwood C, Thomas M, Banks L, Storey A: Role of bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14: 3065–3073, 2000

    Google Scholar 

  43. Lee S, Weiss R, Javier R: Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homologue of the Drosophila discs large tumour suppressor protein. Proc Natl Acad Sci USA 94: 6670–6675, 1997

    Google Scholar 

  44. Kiyono T, Hiraiwa A, Ishii S, Takahashi T, Ishibashi M: Binding of high-risk human papillomavirus E6 oncoproteins to a human homologue of the Drosophila discs large tumour suppressor protein. Proc Natl Acad Sci USA 94: 11612–11616, 1997

    Google Scholar 

  45. Ponting C, Philips C: DHR domains in syntrophins, neuronal NO synthases and other intracellular proteins. Trends Biochem Sci 20: 102–103, 1995

    Google Scholar 

  46. Saras J, Heldin CH: PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem Sci 21: 455–458, 1996

    Google Scholar 

  47. Nakagawa S, Huibregtse J: Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6-AP ubiquitin-protein ligase. Mol Cell Biol 20: 8244–8253, 2000

    Google Scholar 

  48. Glaunsinger B, Lee S, Thomas M, Banks L, Javier R: Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19: 1093–1098, 2000

    Google Scholar 

  49. Kim E, Niethammer M, Rothschild A, Nung Jan Y, Sheng M: Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature 378: 85–88, 1995

    Google Scholar 

  50. Kim S: Polarised signalling: Basolateral receptor localisation in epithelial cells by PDZ-containing proteins. Curr Opin Cell Biol 9: 853–859, 1997

    Google Scholar 

  51. Marfatia J, Lin L, Hough C, Bryant P, Stolz L, Chishti A: Modular organisation of the PDZ domains in the human discs-large protein suggests a mechanism for coupling PDZ domain-binding proteins to ATP and membrane cytoskeleton. J Cell Biol 135: 753–766, 1996

    Google Scholar 

  52. Goode S, Perrimon N: Inhibition of patterned cell shape change and cell invasion by discs large during Drosophila oogenesis. Genes Dev 11: 2532–2544, 1997

    Google Scholar 

  53. Bilder D, Li M, Perrimon N: Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 289: 113–116, 2000

    Google Scholar 

  54. Song S, Liem A, Miller JA, Lambert PF: Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267: 141–150, 2000

    Google Scholar 

  55. Scheffner M, Werness B, Huibregtse J, Levine A, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129–1136, 1990

    Google Scholar 

  56. Huibregtse J, Scheffner M, Howley PM: Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13: 775–784, 1993

    Google Scholar 

  57. Scheffner M, Huibregtse J, Vierstra R, Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495–505, 1993

    Google Scholar 

  58. Gardiol D, Kühne C, Glaunsinger B, Lee SS, Javier R, Banks L: Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18: 5487–5496, 1999

    Google Scholar 

  59. Boyer SN, Wazer DE, Band V: E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56: 4620–4624, 1996

    Google Scholar 

  60. Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A: Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue. Oncogene 19: 5944–5950, 2000

    Google Scholar 

  61. Berezutskaya E, Bagchi S: The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26S proteasome. J Biol Chem 272: 30135–30140, 1997

    Google Scholar 

  62. Kühne C, Gardiol D, Guarnaccia C, Amenitsch H, Banks L: Differential regulation of human papillomavirus E6 by protein kinase A: Conditional degradation of human discs large protein by oncogenic E6. Oncogene 19: 5884–5891, 2000

    Google Scholar 

  63. Phelps WC, Yee CL, Münger K, Howley PM: The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to adenovirus E1a. Cell 53: 539–547, 1988

    Google Scholar 

  64. Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor gene suppressor product. EMBO J 8: 4099–4105, 1989

    Google Scholar 

  65. Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KH: The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J 9: 153–160, 1990

    Google Scholar 

  66. Firzlaff JM, Luscher B, Eisenman RN: Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb binding by the E7 protein of human papillomavirus type 16. Proc Natl Acad Sci USA 88: 5187–5191, 1991

    Google Scholar 

  67. Massimi, P, Banks L: Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle. Virology 276: 388–394, 2000

    Google Scholar 

  68. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Dürr P: Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol 69: 6389–6399, 1995

    Google Scholar 

  69. Zwerschke W, Joswig S, Jansen-Dürr P: Identification of domains required for transcriptional activation and protein dimerisation in the human papillomavirus type-16 E7 protein. Oncogene 12: 213–220, 1996

    Google Scholar 

  70. Rey O, Lee S, Park N-H: Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin. J Virol 74: 4912–4918, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I-34012, Trieste, Italy

    Paola Massimi, David Pim, Christian Kühne & Lawrence Banks

Authors
  1. Paola Massimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Pim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Kühne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lawrence Banks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lawrence Banks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Massimi, P., Pim, D., Kühne, C. et al. Regulation of the human papillomavirus oncoproteins by differential phosphorylation. Mol Cell Biochem 227, 137–144 (2001). https://doi.org/10.1023/A:1013145814186

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013145814186

Search

Navigation